# PALIPERIDONE PALMITATE
> **ANDA216228** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2024-05-20
## Drug
- **FDA Application Number:** ANDA216228
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALIPERIDONE PALMITATE
- **Generic name:** Paliperidone Palmitate
- **Active ingredients:** PALIPERIDONE PALMITATE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INJECTABLE
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMS INC
- **First approval:** 2024-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216228)
---
*AI Analytics · CC0 1.0*